Systemic exposure to hydroxychloroquine and its relationship with outcome in severely ill COVID-19 patients in New York City.

Lyashchenko, Alex K; Yu, Yifan; McMahon, Donald J; Bies, Robert; Yin, Michael T; Cremers, Serge

Lyashchenko, Alex K; Yu, Yifan; McMahon, Donald J; Bies, Robert; Yin, Michael T; Cremers, Serge.

Afiliação

Lyashchenko AK; Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Yu Y; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA.
McMahon DJ; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Bies R; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA.
Yin MT; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Cremers S; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA.

Br J Clin Pharmacol ; 89(1): 299-315, 2023 01.

Article em En | MEDLINE | ID: mdl-35961374

Assuntos

COVID-19; Hidroxicloroquina; Humanos; Hidroxicloroquina/efeitos adversos; Cidade de Nova Iorque; Estudos Retrospectivos; Teorema de Bayes

Palavras-chave

COVID-19; clinical outcome; hydroxychloroquine; pharmacodynamics; pharmacokinetics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Hidroxicloroquina Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google